Leflunomide(HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.

BARTLETT R R; DIMITRIJEVIC M; MATTAR T; ZIELINSKI T; THOENES G H; KUECHLE C C A; SCHORLEMMER H-U; FINNEGAN A; SCHLEYERBACH R

Art

J-GLOBAL ID：200902051570170460 Reference number：91A0394301

Leflunomide(HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.

レフルノミド(HWA486),移植拒否と自己免疫疾患治療に対する新しい免疫調整化合物

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=91A0394301&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=91A0394301&from=J-GLOBAL&jstjournalNo=E0170B") }}

Author (9)： , , , , , , , ,
Material：
Volume： 32 Issue： 1/2 Page： 10-21 Publication year： Jan. 1991
JST Material Number： E0170B ISSN： 0065-4299 Document type： Article
Article type：文献レビュー Country of issue： Switzerland (CHE) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=91A0394301&from=J-GLOBAL&jstjournalNo=E0170B") }}

Basic research of immunotherapeutic agents and blood preparations

, ,

, , , , ,

Return to Previous Page